Bortezomib is a proteasome inhibitor indicated for:
- Treatment of patients with multiple myeloma
- Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy
Bortez Injection সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Bortez